• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Gilead Sciences (NQ: GILD )

    89.51 +0.69 (+0.78%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Gilead Sciences

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    51 52 Next >
    Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine
    These biotech breakthrough stocks give investors a glimpse into medicine's future -- and massive moneymaking opportunities to boot. 
    Via InvestorPlace
    $1000 Invested In This Stock 20 Years Ago Would Be Worth $9,300 Today
    Via Benzinga
    Gilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024
    From Gilead Sciences, Inc.
    Via Business Wire
    Gilead Sciences Unusual Options Activity For May 06
    Via Benzinga
    Bargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Back
    If you want your shot at significant upside, speculate on these stocks near 52-week lows that can prove the critics wrong. 
    Via InvestorPlace
    How Is The Market Feeling About Gilead Sciences?
    Via Benzinga
    Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
    With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Gilead Sciences Unusual Options Activity
    Via Benzinga
    Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar
    These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May. 
    Via InvestorPlace
    Gilead Sciences to Present at Upcoming Investor Conferences
    From Gilead Sciences, Inc.
    Via Business Wire
    3 Dividend Stocks to Buy at a 52-Week Low in April
    Explore these three dividend stocks trading near their 52-week lows, presenting compelling opportunities for income-oriented investors. 
    Via InvestorPlace
    FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
    From Gilead Sciences, Inc.
    Via Business Wire
    Will Gilead's Big Veklury Beat Offset A Cancer Drug Miss?
    Gilead beat first-quarter calls, but it came on the back of Covid drug Veklury. 
    Via Investor's Business Daily
    Exposures COVID-19
    The Analyst Verdict: Gilead Sciences In The Eyes Of 12 Experts
    Via Benzinga
    Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
    GILD earnings call for the period ending March 31, 2024. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    GILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024
    GILD stock results show that Gilead Sciences beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Gilead Sciences Announces First Quarter 2024 Financial Results
    From Gilead Sciences, Inc.
    Via Business Wire
    Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
    Via Benzinga
    Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
    HOOKIPA Pharma secures FDA clearance for its innovative HB-700 therapeutic vaccine targeting KRAS-mutated cancers. Learn about its broad impact on lung, colorectal, and pancreatic cancers, achieving... 
    Via Benzinga
    Exposures Product Safety
    What the Options Market Tells Us About Gilead Sciences
    Via Benzinga
    If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
    Via Benzinga
    Why the dividend investor may take a look at NASDAQ:GILD.
    Uncovering Dividend Opportunities with GILEAD SCIENCES INC (NASDAQ:GILD). 
    Via Chartmill
    Stocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
    Wall Street suffers a double blow in Thursday’s session, as softer-than-expected revenue forecasts from Meta Platforms Inc. (NASDAQ:META) are being compounded by weaker-than-expected economic growth... 
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Undervalued Icons: 3 Household Names Trading at Steep Discounts
    Three of Wall Street's undervalued stocks could provide a unique blend of stability and long-term growth potential. 
    Via InvestorPlace
    FDA Mandates "Boxed Warning" For Bristol Myers, Johnson & Johnson CAR-T-Based Blood Cancer Therapies
    Following an investigation announced in November last year, the FDA said on Thursday that it would now require boxed warnings—the highest safety-rel 
    Via Benzinga
    Exposures Product Safety
    US Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
    The back-and-forth motion in the market continues, with the index futures pointing to a lower opening on Thursday. Meta Platforms, Inc.’s (NASDAQ:META) 
    Via Benzinga
    Better Growth Play: Merck or The Vanguard Growth Index Fund?
    Merck's shares are trading in bargain territory. Are they a better growth play than this popular Vanguard fund? 
    Via The Motley Fool
    Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
    Corporate profit growth rose in Q3 2023 and is expected to continue in Q1. 
    Via Benzinga
    Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
    Dividend stocks can be a smart way to ride out market volatility. 
    Via The Motley Fool
    Biotech Innovations Paving the Way in Breast Cancer Fight
    EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:GILD),(NASDAQ:GTHX),(NASDAQ:AZN),(NASDAQ:HOLX) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Topics Death
    Exposures Death Product Safety
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    51 52 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.